Stockscreener 앱 받기
108.18
0.92%
-1.00
전일 마감가:
$109.18
열려 있는:
$109.09
하루 거래량:
10.48M
Relative Volume:
0.78
시가총액:
$268.51B
수익:
$63.90B
순이익/손실:
$19.05B
주가수익비율:
14.31
EPS:
7.5596
순현금흐름:
$13.05B
1주 성능:
-0.60%
1개월 성능:
+2.99%
6개월 성능:
+28.82%
1년 성능:
+11.95%
1일 변동 폭
$107.21
$109.09
1주일 범위
$106.93
$111.97
52주 변동 폭
$73.31
$112.90
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
MRK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
108.18 | 270.99B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
LLY
Lilly Eli Co
|
1,064.29 | 973.23B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
220.14 | 526.41B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
219.26 | 385.48B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
147.14 | 278.22B | 54.45B | 14.42B | 17.15B | 7.333 |
|
NVO
Novo Nordisk Adr
|
62.26 | 276.52B | 46.69B | 15.29B | 9.25B | 3.4329 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck & Co., Inc. (MRK) and CEPI Launch Effort to Make Ebola Vaccine Cheaper and Easier to Distribute - Insider Monkey
Merck & Co., Inc. $MRK Shares Sold by TFR Capital LLC. - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Sector Gamma AS - MarketBeat
Sagespring Wealth Partners LLC Purchases 13,778 Shares of Merck & Co., Inc. $MRK - MarketBeat
iA Global Asset Management Inc. Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Cullen Frost Bankers Inc. - MarketBeat
Commerzbank Aktiengesellschaft FI Has $29.15 Million Position in Merck & Co., Inc. $MRK - MarketBeat
1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income - The Motley Fool
Merck & Co., Inc. $MRK Shares Sold by Symphony Financial Ltd. Co. - MarketBeat
Mn Services Vermogensbeheer B.V. Has $80.17 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Purchases 142,125 Shares of Merck & Co., Inc. $MRK - MarketBeat
UniSuper Management Pty Ltd Buys 160,345 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock - Chartmill
ARGA Investment Management LP Cuts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Teacher Retirement System of Texas Sells 199,740 Shares of Merck & Co., Inc. $MRK - MarketBeat
UNIVEST FINANCIAL Corp Sells 18,610 Shares of Merck & Co., Inc. $MRK - MarketBeat
Strs Ohio Boosts Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Oncolytic Virotherapy Market - GlobeNewswire Inc.
Merck & Co., Inc. (NYSE:MRK) Shares Down 1.7%Here's What Happened - MarketBeat
How To Win Deals In A Competitive Market, With Merck & Co. BD Exec Elizabeth Naldi-Jacob - Citeline News & Insights
User - The Chronicle-Journal
Merck unit partners with global health coalition to develop affordable Ebola vaccine - Reuters
Simplicity Wealth LLC Sells 43,336 Shares of Merck & Co., Inc. $MRK - MarketBeat
Boston Common Asset Management LLC Has $20.79 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Bailard Inc. Sells 30,041 Shares of Merck & Co., Inc. $MRK - MarketBeat
Allergic Rhinitis Treatment Market Is Booming Worldwide | Merck - openPR.com
Merck added to BofA's best ideas list—see all the names - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Stock Price Up 1.5% on Analyst Upgrade - MarketBeat
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for InvestorsContact Levi & Korsinsky - The National Law Review
Merck & Co., Inc. $MRK Stock Position Boosted by Joel Isaacson & Co. LLC - MarketBeat
Broader Analyst Sentiment Bullish on Merck & Co. (MRK) Amid Tempered Short-Term Expectation and Long-Term Optimism - Finviz
Merck & Co (MRK) to Generate $70 Billion in Revenue from Emerging Businesses By Mid-2030s - Insider Monkey
Merck stock added to BofA US 1 List, Apple remains on select portfolio - Investing.com
Dynasty Wealth Management LLC Takes $1.02 Million Position in Merck & Co., Inc. $MRK - MarketBeat
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. In - The National Law Review
Merck/Moderna Intismeran Data Show Continued Efficacy In Melanoma - Citeline News & Insights
Moderna–Merck Cancer Vaccine Shows Durable Benefit At 5 Years In High-Risk Melanoma - Benzinga
Moderna, Merck's skin cancer vaccine shows sustained benefit in five-year follow-up - Reuters
Merck (MRK) Builds Post-Keytruda Growth Plan, BMO Upgrades to Outperform - Finviz
Merck & Co (MRK) Analyst Rating: TD Cowen Raises Price Target to $120 | MRK Stock News - GuruFocus
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Merck & Co., Inc. Stock (MRK) Opinions on Pipeline Revenue Projections - Quiver Quantitative
Turtle Creek Wealth Advisors LLC Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Moderna-Merck Skin Cancer Treatment Shows Long-Term Benefits - Bloomberg
Merck & Co., Inc. (MRK) Poised for Breakout After Strategic M&A and Pipeline Expansion - Finviz
Merck & Co., Inc. (NYSE:MRK) S&P 500 Fund Healthcare Scale - Kalkine Media
Lobbying Update: $30,000 of TIBER CREEK GROUP ON BEHALF OF MERCK & CO. INC. lobbying was just disclosed - Quiver Quantitative
Wealth Enhancement Advisory Services LLC Acquires 98,009 Shares of Merck & Co., Inc. $MRK - MarketBeat
NorthCrest Asset Manangement LLC Buys 81,276 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lowered by Massachusetts Financial Services Co. MA - MarketBeat
Allstate Corp Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.67%
자본화:
|
볼륨(24시간):